Your browser doesn't support javascript.
loading
Evaluation of Lipid Profile and Residual Cardiovascular Risk in Patients Prior to Initiation of Niaspan Therapy.
Islam, Syed; Danwada, Raghava; Ganguli, Minoti; Espaillat, Ramon; Jarvis, Michael; Bacher, H Peter.
Afiliação
  • Islam S; AbbVie Pharmaceuticals, Lake Bluff, IL, USA.
  • Danwada R; AbbVie Pharmaceuticals, Lake Bluff, IL, USA.
  • Ganguli M; AbbVie Pharmaceuticals, Lake Bluff, IL, USA.
  • Espaillat R; AbbVie Pharmaceuticals, Lake Bluff, IL, USA.
  • Jarvis M; AbbVie Pharmaceuticals, Lake Bluff, IL, USA.
  • Bacher HP; AbbVie Pharmaceuticals, Lake Bluff, IL, USA.
J Pharm Technol ; 34(1): 3-8, 2018 Feb.
Article em En | MEDLINE | ID: mdl-34860936
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2018 Tipo de documento: Article